Strain Information | |
---|---|
Image | |
BRC No. | RBRC04947 |
Type | Transgene |
Species | Mus musculus |
Strain name | B6.B6D2-Tg(CAG-Fad24)L2-5Maim |
Former Common name | Fad24 Tg |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Department of Molecular Biology, Graduate School of Pharmaceutical Sciences, Nagoya City University in 2006. The line L2-5 and L4-3 were mainly used. |
Strain description | Transgenic mice having a mouse fad24 under control of the CAG promoter. |
Colony maintenance | Carrier x Noncarrier [C57BL/6J(Crlj)] |
References | Biol. Pharm. Bull., 32, 1656-1664 (2009). 19801824 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Noc3lnucleolar complex associated 3 homolog (S. cerevisiae)UNNoc3ltransgene insertion L2-5, Masayoshi ImagawaFactor for adipocyte differentiation 24 (fad24)CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA) |
Ordering Information | |
---|---|
Donor DNA | mouse Factor for adipocyte differentiation 24 (fad24) gene cDNA, CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA) |
Research application | Diabetes and Obesity Research covid19_progression |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Biol Pharm Bull. 2009 32(10):1656-64. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from Dr.Makoto Nishizuka (nishizuka@hirosaki-u.ac.jp) using the Approval Form. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Masayoshi Imagawa (Nagoya City University) |
Strain Status | Frozen embryos |
Strain Availability | Recovery and QC required prior to distribution |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |